Skip to content

The preventive and therapeutic effects of Qishen Yiqi Dropping Pills on early ventricular remodeling in STEMI patients with heart failure

The preventive and therapeutic effects of Qishen Yiqi Dropping Pills on early ventricular remodeling in STEMI patients with heart failure

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300076214
Enrollment
Unknown
Registered
2023-09-27
Start date
2023-10-01
Completion date
Unknown
Last updated
2023-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute myocardial infarction

Interventions

Qishen Yiqi:Within 24 hours after PCI, 0.5g (1 bag) of Qishen Yiqi Dropping Pills was administered on the basis of GDMT for 6 months per day.
Control:Western medicine treatment guided by guidelines

Sponsors

The Second Hospital of Hebei Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: ? Age 18-75 years old; ? For the first onset of STEMI, emergency PCI or early PCI after thrombolysis should be performed within 24 hours of onset; ? Killip level II-III; ? LVEF measured by echocardiography within 24 hours after PCI was less than 50%.

Exclusion criteria

Exclusion criteria: Patients with claustrophobia, a history of coronary artery bypass grafting, or previous myocardial infarction, implanted pacemakers other than MRI safe pacing systems, metal heart valves, metal foreign bodies, decompensated heart failure, arrhythmias, musculoskeletal diseases, liver and kidney dysfunction, cardiogenic shock, or the need for ventricular assist devices, participating in other clinical trials, allergic or intolerant to investigational drugs, Patients and family members refuse.

Design outcomes

Primary

MeasureTime frame
LVEDV;

Secondary

MeasureTime frame
Major adverse cardiac events;

Countries

China

Contacts

Public ContactWang Yanbo

The Second Hospital of Hebei Medical University

doctorwangyanbo@126.com+86 139 3185 8363

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026